standard-logotype-light

Unlock the Financial Power of Social Risk Insights

Turning social risk into measurable financial performance

Health plans face increasing pressure to improve outcomes, manage total cost of care, and succeed under value-based contracts, all while navigating tighter margins and rising member complexity. Most payers rely on clinical analytics to manage these pressures, yet many drivers of cost and outcome variation lie outside traditional clinical data. Among them, social risk is one of the most impactful and least operationalized drivers of financial performance.

Why is SDOH data so difficult to operationalize?

Although many payers recognize social risk matters, fragmented and unstructured SDOH data siloed from clinical and claims systems limits their ability to measure impact or incorporate social risk into financial planning.

When unified with claims, pharmacy, and clinical data, social risk insights become measurable, targetable, and actionable. Payers can then allocate resources with confidence and link social interventions directly to financial performance.

Leadership from BCBS South Carolina discuss the value of SDOH data in today's complex healthcare landscape.

A scalable framework for quantifying and managing the financial impact of social risk

Payers have historically lacked a comprehensive approach to measuring and managing the financial impact of social risk—until now.

Developed in partnership with Socially Determined and Mathematica, Social Risk Insights Measures & Outcomes provides an enterprise-ready framework that combines actuarial rigor with real-time analytics.

Visibility

Socially-Determined

Social Risk Identification:

Quantifies social risk as a real driver of utilization and cost

Integration

full-logo-dark

Data Integration
& Platform Delivery: 

Embeds that signal directly into claims, forecasting, and financial workflows.

Confidence

mathematicawithtagline560 (1)

ROI Modeling
& Actuarial Validation:

Enables defensible, forward-looking investment decisions — validated and repeatable.

Social risk is not a separate initiative. It is a performance lever.

Unlike traditional social determinants of health (SDOH) approaches, MedeAnalytics’ Social Risk Insights Measures & Outcomes integrates validated social risk intelligence with existing data, allowing payers to quantify impact, allocate resources strategically, and demonstrate measurable return on investment (ROI).

It enables payers to:

Explain cost variation within clinically similar populations

Identify overlooked, high-impact sub-populations

Target interventions that maximize financial and quality performance

Validate ROI using accepted actuarial methodologies

Scale proven programs across lines of business

Start turning social risk insights into financial strategy

Social risk is not a secondary quality initiative. It is a measurable predictor of cost, utilization, and performance. MedeAnalytics enables you to identify hidden cost drivers, prioritize high-risk cohorts, and act with confidence using a proven, data-driven approach.

Learn more about how Social Risk Insights Measures & Outcomes drives quantified savings

A comprehensive examination of the methodology, validation, and financial impact of operationalizing social risk

With Social Risk Insights Measures & Outcomes, payers receive:

check-purple

Quantified financial impact through actuarially validated insights into cost reduction and utilization avoidance

check-purple

Improved value-based performance, including more accurate risk adjustment and stronger contract outcomes

check-purple

Precision resource allocation that focuses care management and social investment where returns are greatest

check-purple

Executive confidence supported by decision-ready analytics for budgeting, rate setting, and strategic planning

Risk-cohorts

Proof that social risk is a financial lever

A opportunity assessment conducted for a large commercial plan found that integrating social risk into payer analytics revealed the underlying drivers of cost variation among clinically similar members.

The study identified five population cohorts with the greatest potential for financial impact, amounting to as much as $25M in validated cost savings.

$M
in validated cost savings across 5 targeted cohorts

Social risk is no longer a compliance exercise or pilot program.
It is a measurable driver of financial performance.

Try it for yourself — let us quantify the opportunity in your own data. Through our Opportunity Assessment, we will:

  1. Score social risk at the member level
  2. Integrate risk, claims, and pharmacy data into a unified dataset
  3. Stratify risk and modeling interventions for top opportunity cohorts
  4. Estimate ROI for targeted interventions
  5. Deliver a report with recommended actions and savings potential

Inquire today about how Social Risk Insights Measures & Outcomes can help you gain earlier insight, sharper prioritization, and repeatable, scalable returns.

© 2026 MedeAnalytics, Inc. All rights reserved | Terms of Use  | Privacy Statement